Holicort 6 Tablet contains Deflazacort 6 mg, a corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain dermatological disorders. Deflazacort exerts its therapeutic effects by modulating the immune response and reducing inflammation through inhibition of multiple inflammatory mediators. Holicort 6 is also utilized in the treatment of certain muscular dystrophies to improve muscle strength and function. The medication is administered orally and should be used under strict medical supervision, with dosing individualized according to the severity of the condition and patient response. Common side effects may include gastrointestinal disturbances, increased susceptibility to infections, hyperglycemia, and potential adrenal suppression with prolonged use. Patients should be monitored regularly for adverse effects, and gradual tapering is recommended to avoid withdrawal symptoms. Caution is advised in patients with diabetes, hypertension, osteoporosis, or peptic ulcer disease. Holicort 6 should not be discontinued abruptly without consulting a healthcare professional. Overall, Holicort 6 Tablet offers an effective therapeutic option for controlling inflammation and modulating immune-mediated diseases when used appropriately.